Sustainability | July 10, 2024
Synexa Life Sciences enrolls in My Green Lab Certification Program
The My Green Lab Certification is the gold standard for laboratory sustainability practices worldwide
The My Green Lab Certification is the gold standard for laboratory sustainability practices worldwide
Olverembatinib, a novel drug developed by Ascentage Pharma with support from the National Major New Drug Development program
Aim of the collaboration is to develop mRNA platform technology, scale up and troubleshoot challenges in mRNA process optimization
CureVac receives €400 million upfront and up to an additional €1.05 billion in development, regulatory and sales milestone payments as well as tiered royalties; all previous financial considerations from the prior collaboration agreement replaced
The expiry date of almost all strips is rubber stamped vanish in a matter of 3 to 4 months, making the remaining tablets waste for subsequent use before expire date
Submission based on positive SUPERNOVA Phase III trial data which demonstrated a statistically significant reduction in the incidence of COVID?19 in an immunocompromised patient population
An investigational CYP11A1 Inhibitor, for the treatment of metastatic castration-resistant prostate cancer
Laurus Labs receives EIR from USFDA for API facilities
Signs MoUs with Shri Krishna Ayush University and Dabur India
The company has been entrusted with the responsibility of supplying a wide range of essential oncology drugs
Subscribe To Our Newsletter & Stay Updated
